Mechanistic models of α-synuclein homeostasis for Parkinson's disease: A blueprint for therapeutic intervention

3Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

Parkinson's disease (PD) is the second most common neurodegenerative disorder worldwide, yet there is no disease-modifying therapy up to this date. The biological complexity underlying PD hampers the investigation of the principal contributors to its pathogenesis. In this context, mechanistic models grounded in molecular-level knowledge provide virtual labs to uncover the primary events triggering PD onset and progression and suggest promising therapeutic targets. Multiple modeling efforts in PD research have focused on the pathological role of α-synuclein (αsyn), a presynaptic protein that emerges from the intricate molecular network as a crucial driver of neurodegeneration. Here, we collect the advances in mathematical modeling of αsyn homeostasis, focusing on aggregation and degradation pathways, and discussing potential modeling improvements and possible implications in PD therapeutic strategy design.

Cite

CITATION STYLE

APA

Righetti, E., Antonello, A., Marchetti, L., Domenici, E., & Reali, F. (2022, December 16). Mechanistic models of α-synuclein homeostasis for Parkinson’s disease: A blueprint for therapeutic intervention. Frontiers in Applied Mathematics and Statistics. Frontiers Media S.A. https://doi.org/10.3389/fams.2022.1060489

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free